Research and Markets (http://www.researchandmarkets.com/research/8f18b5/delivering_rnaiba) has announced the addition of the "Delivering RNAi-Based Therapeutics & Diagnostics: Challenges & Opportunities" report to their offering.
This cutting edge & insightful report can be used to interpret & assess the potential of RNAi-based medicines. It provides opinions & market projections to:
- assess the commercial potential of RNAi-based therapies in all of the key therapeutic areas: cancer, CNS disorders, viral infectious diseases, ocular diseases, cardiovascular, metabolic and other conditions;
- identify key pharma & delivery specialists advancing RNAi-based therapeutics & diagnostics;
- gain an in-depth understanding of the technological & delivery issues which face companies developing RNAi-based therapies;
- evaluate the options available for chemically and structurally modifying RNAi silencing agents and delivering them to target tissues now & in the future;
- discover which companies are tackling efficacy and safety issues & are in a prime position to exploit new opportunities;
- analyze how the market will evolve over the next decade highlighting key trends, opportunities & challenges.
SOME KEY FINDINGS: